Author Archive

FDA Is Departing from Long-Standing Procedures to Deal with Public Health Crises, and This May Foreshadow Problems for COVID-19 Vaccines

The rushed emergency approval for a treatment that might help COVID-19 patients has raised questions: Is the FDA abandoning its own guidelines?

• Ana Santos Rutschman, Lisa Vertinsky and Yaniv Heled, The Conversation
• August 27, 2020